chr6-89613840-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001242809.2(ANKRD6):āc.565A>Gā(p.Ile189Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000929 in 1,613,918 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001242809.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD6 | NM_001242809.2 | c.565A>G | p.Ile189Val | missense_variant | 7/16 | ENST00000339746.9 | NP_001229738.1 | |
LOC124901359 | XR_007059673.1 | n.205+7881T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD6 | ENST00000339746.9 | c.565A>G | p.Ile189Val | missense_variant | 7/16 | 1 | NM_001242809.2 | ENSP00000345767 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 249242Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135212
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461700Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727136
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 31, 2023 | The c.565A>G (p.I189V) alteration is located in exon 7 (coding exon 6) of the ANKRD6 gene. This alteration results from a A to G substitution at nucleotide position 565, causing the isoleucine (I) at amino acid position 189 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at